|
Activities, Bill Numbers and Titles
|
|
|
|
Client: Pharmaceutical Research and Manufacturers of America (PhRMA)
|
|
|
|
House Bill
|
4045
|
An Act to promote growth and opportunity
|
Neutral
|
$94.36
|
N/A
|
|
Senate Bill
|
2176
|
An Act relative to the substitution of interchangeable biosimilars
|
Support
|
$94.36
|
N/A
|
|
Executive
|
|
Health Policy Commission's proposed patient-centered medical home criteria for certification
|
Support
|
$283.08
|
N/A
|
| | | |
Total amount
|
$471.80
| |
|
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|